Recent advancements in cardiac regeneration research have led to innovative therapies that aim to enhance the healing process after cardiac injury. Preclinical studies and early-phase clinical trials are exploring the safety and efficacy of various regenerative approaches. These may involve the transplantation of stem cells, the use of growth factors to stimulate tissue repair, or the development of bioengineered cardiac patches that can be implanted to replace damaged tissue. The ultimate goal is to develop interventions that not only repair the structural damage caused by heart diseases but also restore optimal cardiac function. While challenges and complexities remain, the potential for cardiac regeneration to transform the landscape of cardiovascular medicine is driving continued research and collaboration among scientists, clinicians, and experts in regenerative medicine.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India